The workup ischemic heart disease (IHD) before selection medical-surgical or medical therapy depends on multiple objective and subjective factors. These include symptoms, extent of anatomic disease (degree of coronary arteriosclerosis and left ventricular abnormalities), objective evidence of ischemia, extent of left ventricular dysfunction, and recent intercurrent ischemic events. In a minority of patients, a single factor i's of overwhelming importance; e.g., the presence of severe left main coronary artery narrowing in, a symptomatic patient indicates surgery is a better choice, whereas evidence of advanced left ventricular dysfunction suggests that surgery is likely to be nrsky and of limited help to the patient. In most instances, multiple factors should be considered before making a recommendation. The patient should be placed in the appropriate clinical subset and the objective factors that are most important in determining survival should be evaluated. Hence, an exercise electrocardiographic study to evaluate symptoms and exercise tolerance in a patient with angina pectoris and radioventriculographic studies with exercise to estimate left ventricular performance in a patient who complains of fatigue and breathlessness are superior to the subjective interpretations of routine clinical examinations. Asymptomatic patients and those with excellent exercise tolerance pose the most difficult decisions. Perhaps serial (even annual) noninvasive evaluation is appropriate in such patients in light of the current uncertainty about how to manage them. Laboratory tests should be used selectively, systematically and sequentially. The high cost of many of the examinations is reason to aivoid duplication. When noninvasive evaluation can answer the question being posed and the cost of hospitalization avoided, this should be done. However, there is little reason to perform noninvasive examinations that do not answer the clinical question being asked; hence, in many patients it is appropriate to proceed directly to coronary arteriography rather than to perform a variety of "screening" examinations before this procedure.
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Ischemic Heart Disease THE NATURAL HISTORY of ischemic heart disease (IHD) has been a topic of interest for many years,'but it was during the early 1970s that intensive investigative and clinical efforts established the relative importance of various factors in estimating the prognosis of IHD.7-'6 The literature on the subject is extensive and no attempt will be made to review it. Development of coronary bypass surgery and its widespread application in many clinical situations has highlighted the need for better prognostic data. In the last 5 years, huge series of patients with IHD who were treated surgically have been reported. Some of the reports are of hundreds or thousands of patients and from single institutions, others involve randomized trials in this country and in Europe and some studies are ongoing. '6-22 The Coronary Artery Surgery Study (CASS) sponsored by the National Heart, Lung, and Blood Institute promises to add significantly to our understanding of the natural history of IHD, at least insofar as the data indicated in the late 1970s.
In attempting to evaluate the results of these studies and reach a consensus concerning the optimal workup for a patient with IHD, it is unfortunate that multiple factors have been changing during the time these vast amounts of data have accumulated. The techniques for evaluating the patients have become more sophisticated and precise and surgical methods have changed dramatically. Perioperative care and techniques to protect the myocardium during surgery have produced major reductions in morbidity and mortality rates. Additional -new methodologic approaches are now being applied medically, including use of calcium antagonists in the United States, balloon dilatation of coronary arteries, enzymatic treatment of fresh thrombosis in coronary arteries and drug therapies of arrhythmias, that "complicate". the situation further in reference to patient workup and selection of a therapeutic modality.
The considerations just mentioned make apparent that no straightforward approach to the evaluation of the patient with IHD will have wide consensus. In addition to the usual differences of opinion to be anticipated among clinicians, it is the complexity of the problem, the disparity of opinions regarding what constitutes an "acceptable" outcome and the fact that the medical profession is evolving a better understanding of prognosis that prevents any simple and unified approach from developing. The schemes outlined subsequently rely on the extensive published data available, but no comprehensive statistical approach is possible. Obviously, they are heavily dependent on my own personal experiences (i.e., clinical "biases").
The best selection of therapy must be based on knowledge of prognosis and the extent to which prognosis can be altered by the management strategies being considered. The workup must provide enough data to estimate prognosis relative to the medicalsurgical or medical therapy being considered. Table 1 lists the principal prognostic determinants in all patients with chronic IHD. The simplicity of the [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Data are not available to apply specific analytic techniques to these multiple prognostic factors (e.g., a method of discriminant analysis, which has been used so successfully for other disorders such as acute myocardial infarction). 23 The degree of left ventricular dysfunction may be the most important prognostic determinant, but the issues involved are complex. In a specific patient, a recent intercurrent ischemic event is of major prognostic significance for the short-term outlook (a few months to a year). In addition, sudden cardiac death with successful resuscitation, especially in the absence of acute myocardial infarction, worsens the short-term prognosis considerably. Sudden cardiac death may be an "electrical" rather than an "ischemic" event. The whole area of the specific contribution of arrhythmias to prognosis is only minimally included in this discussion because it remains an unusually complicated and generally unresolved issue. The principal difficulty relates to determining how much of a contribution ventricular arrhythmias make to prognosis beyond the contribution of left ventricular dysfunction, severity of myocardial ischemia, degree of coronary arteriosclerosis and the other factors that are under consideration. Table 2 outlines the principles involved in the workup of a patient with IHD. Although they may appear to be quite straightforward, their application can be extremely difficult in a given situation unless the physician considers clearly and precisely the question he is asking for each specific patient. It seems particularly easy to overstate knowledge about the natural history of IHD, frequently utilizing data obtained many years ago to substantiate a decision made in the 1980s. Similarly, it is easy to be unduly biased by the patient's recent complaints and fail to consider the whole clinical course. It has been particularly difficult in recent years to avoid redundancy in the use of laboratory tests. Table 2 also outlines some of the problems in clinical decision making that are related to our changing technology, our improved understanding of prognostic factors and the changes that have occurred in both medical and surgical therapies in recent years that diminish the value, at least in a statistical sense, of the prognostic data published as recently as 6-10 years ago. Table 3 lists what might be termed human factors that modify the approach to the workup; in certain circumstances, these factors weigh heavily in clinical decision making. It is the nature of clinical practice that these human factors are important, but they should not be the primary factors in decision making in most patients.
Three clinical subsets of patients will be discussed because they constitute a large majority of patients with chronic IHD who are evaluated and they amply illustrate the principles and problems. Table 4 depicts the approach to decision making for patients with stable angina pectoris (SAP).
Stable Angina Pectoris
SAP may be defined as ischemic cardiac discomfort predictably brought on by factors that increase myocardial oxygen consumption and relieved promptly by nitroglycerin or by removing the precipitating factors. The complaint should have been present in an unchanging fashion for 4-6 months before it is judged to be stable. Medical history alone is the most effective way to establish the diagnosis of SAP. A reasonable current estimate of prognosis for patients with SAP is an average 3-5% annual mortality. Little additional prognostic information can be obtained fro-m the medical history except in patients in whom the discomfort has been present for substantially more than 5 years and when it is frequent and A. Place patients into subsets relative to multiple important prognostic determinants B. Develop keen appreciation of "natural history" (and detailed knowledge of local surgical results) C. Utilize stepwise approach, first performing the simplest, least hazardous, and least expensive examinations ifthey provide the information needed D. Objective/ quantitative data are superior to subjective qualitative data E. Determine if the management strategy is to improve symptoms, prevent complications or prolong life (all will not be achieved in many patients) F. Avoid redundancy and duplication in the workup and always consider "cost and benefits" Problems A. Changing technology to provide better diagnostic information and therapy B. Improved understanding of prognostic factors C. Propensity for coronary arteriosclerosis to progress but at a variable rate D. Very low incidence of death and complications at surgery Desires and anxieties of patient 3.
Anxieties of the physician 4.
Local interests and practices 5.
Local "results" of diagnostic tests and management strategies can be easily provoked. In such patients the prognosis can be assumed to be worse than average. However, many patients learn to avoid situations that produce the discomfort, use nitroglycerin prophylactically or otherwise manage their affairs in a way to minimize their complaints and therefore give a "misleading" history in reference to the severity of their ischemia. Exercise testing is nearly always of some value in patients with SAP, to provide at least baseline data for future reference if nothing else. Exercise testing is particularly worthwhile in patients whose SAP does not limit usual activities. If such patients have normal exercise tolerance with little or no electrocardiographic change, their short-term outlook (next several years) is excellent and medical therapy is reasonable. An annual mortality of as low as 1% or 2% can be predicted in these patients. If the patient is older, has few physical demands on him or her and is satisfied with his physical status (Course 1 on the flow chart [table 3]), medical therapy would seem to be a particularly appealing course. If exercise is limited to a significant degree or prominent ST segments occur, angiography should be the next step because disease justifying surgery is likely to be present (Course 2). When electrocardiographic changes are equivocal, difficult to interpret because of resting electrocardiographic changes, associated diseases or drugs or when exercise seems limited by noncardiac factors, nuclear cardiologic methods may provide insights into the stage of the patient's IHD. In some patients (my opinion), nuclear cardiology examinations add additional information and provide the data necessary to make a decision for medical therapy (Course 3). However, if regional wall motion abnormalities or perfusion defects of certain characteristics occur, such data may provide the stimulus to proceed to angiography before final decision making (Course 4). There is general agreement that radioventriculography with exercise provides more data and is more easily interpretable than thallium perfusion studies. However, the precise role of these studies in routine evaluation and the additive value of such studies to more easily obtained, and less expensive, evaluations are not clear. Early studies in rather selected subsets of patients are promising, but many more data need to accumulate before such evaluations are recommended for routine practice.2' 24 Depending on the nature of the referral practice, many patients with SAP have complaints that limit their normal activity. In such patients, results of exercise electrocardiography and nuclear cardiologic examinations are of interest but are redundant because the patient's symptomatic state is the justification for angiographic study as a prelude to considering surgery. Proceeding directly to angiography is an approach that is arguable by some who contend that only after intensive medical therapy involving multiple drugs is one justified in pursuing angiography. Some physicians believe that exercise testing after trial of multiple drugs, objectively demonstrating an improvement (or lack of improvement) and exercise tolerance, should be invoked. Most data and experience indicate that the use of multiple drugs in patients who are truly limited by SAP renders only an extremely small percentage of patients symptom-free. Hence, it seems rational to proceed directly to coronary arteriography in the case of a patient who has had a reasonable trial of drugs but whose discomfort continues to limit the patient's normal activity (Course 5).
Patients with conspicuously poor left ventricular function constitute special problems and liabilities. If overt congestive heart failure due to global left ventricular dysfunction without angina pectoris is the patient's principal limitation, a detailed evaluation is not justified. An aneurysm must be excluded, but it is usually possible to make an accurate assessment from the patient's clinical course, the results of clinical examination, the electrocardiographic data and chest roentgenograms. A clinical course, usually measured in years, with multiple myocardial infarctions by clinical and electrocardiographic assessment together with evidence of diffuse cardiomegaly, sometimes with a third heart sound, or findings indicative of extensive scarring and global dysfunction virtually ensures the diagnosis of global dysfunction. Electrocardiographic suspicion of an aneurysm because of persistent STsegment elevation or the presence of an ectopic impulse on physical examination constitute an indication to proceed to additional laboratory examinations to exclude the possibility of an aneurysm. A radioventriculographic study while the patent is at rest is the preferred choice. In patients with poor left ventric-Abbreviations: LV = left ventricular; ECG = electrocardiogram.
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VOL 65, SUPPL II, JUNE 1982 ular function in whom angina constitutes the principal limitation, a radioventriculogram can be obtained to help make the decision of whether or not to perform an angiographic study. Particularly astute clinical judgment is needed in such patients because no arbitrary lower limit can be set as a contraindication for surgery in these patients, although it seems certain that ejection fractions less than 25-30% characterize patients in whom the surgical mortality is higher and the outcome much less satisfactory than in patients with angina whose ejection fraction is only slightly reduced or within the normal range.
Unstable Angina Pectoris
An approach to decision making in patients with unstable angina pectoris is illustrated in the flow chart in table 5. There is a reasonable consensus on the approach to patients in this subset. Observation for 24-72 hours after hospital admission to allow symptoms to be controlled, to search for contraindications for coronary artery bypass surgery and to rule out myocardial necrosis and obtain confirmatory information for the diagnosis (e.g., electrocardiographic study during pain) is indicated. Radioventriculography can be a valuable adjunct to assess left ventricular function in those patients in whom clinical findings suggest that major left ventricular dysfunction is present. In the absence of a contraindication to surgery, coronary arteriography is nearly always indicated. Although some subsets can be assumed to have advanced coronary arteriosclerosis (principally patients with longstanding IHD), the degree of disease is often not easily predictable by any clinical feature or the patient's response to therapy. In patients with advanced coronary arteriosclerosis, even if a good response to therapy is achieved, many require early bypass surgery because of recurrent symptoms or development of limiting SAP. Delay of surgery risks complications and probably adds to the expense of therapy. 25 Medical therapy may be selected in those patients who have limited disease, particularly when it is judged that spasm may be playing a major role. Although many physicians now believe that medical-surgical therapy is indicated in all patients with unstable angina who have advanced arteriographic disease, regardless of their early response to therapy, decisions concerning management of this group of patients still provide an opportunity to individualize care. With the newer therapies available, medical therapy can be selected in patients with limited disease, particularly when it is suspected that spasm may be playing a major role. In addition, the National Cooperative Study20' 21 on unstable angina provides evidence that the in-hospital and short-term outcome of patients with unstable angina (excluding patients who have left main coronary artery disease) is not different for medical or surgical treated groups with respect to mortality. Symptomatic improvement is greater in the surgically treated group. A recent study from Ireland26 is particularly provocative in emphasizing the relatively favorable 1-year outcome in patients with table 6 depicts an approach to evaluation of the patient postinfarction. The complexity of the flow chart emphasizes that no simple approach is appropriate in such a complicated situation. A few patients have limiting and recurrent ischemic symptoms early after their infarction, and evaluation in the first few weeks, usually before discharge from the hospital, is justified. The approach in these patients is to proceed directly to angiographic study and make a decision regarding management. In some of these patients, it may be important to get an estimate of left ventricular function to be certain that there is not a contraindication to surgery or that an aneurysm is not present. An aneurysm is usually suspected or can be diagnosed relatively confidently from the electrocardiographic changes and evidence of an ectopic impulse during the physical examination. In patients who have had a satisfactory convalescence from their infarct (i.e., have no angina or heart failure), an evaluation should be undertaken a few weeks after the infarction. The first step in the evaluation is an exercise electrocardiographic study. Although exercise testing before hospital discharge has been advocated by some and shown to be safe, there is no convincing evidence that it enhances patient management in patients who are stable, minimally or not symptomatic and are being followed closely. Exercise techniques are not standardized, but some kind of graded exercise testing performed before a decision concerning the patient's return to work seems sensible. If exercise testing shows good exercise tolerance, i.e., no symptoms or ischemic change during the exercise, it is reasonable to make a decision for further medical management (Course 1 on the flow chart). If exercise tolerance is sharply limited or ischemia occurs on the basis of clinical or electrocardiographic evidence, then angiographic study should be recommended33 (Course 2 on the flow chart). In a group of patients in whom exercise testing is equivocal with respect to interpretation, nuclear cardiologic methods, particularly radioventriculography with exercise, may be extremely useful and can lead to either a decision for medical therapy (Course 3) or the need to proceed to angiographic study before a decision is made (Course 4). The approach outlined for this subset of patients is similar for any asymptomatic group.
In the group of patients who have angina pectoris early in the postinfarction period during mild exercise, it seems reasonable to proceed directly to the angio-graphic study before making a decision about management plans. As is true in all groups of patients, exercise testing is of value in these patients but is not essential nor will it likely negate the decision to proceed to angiography.
